COVID-19 Impact on Global Powder-based Needle Free Injector, Market Insights and Forecast to 2026
- BMR3897544
- 116 Pages
- June 2020
- Medical Devices
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Powder-based Needle Free Injector industry.
Based on our recent survey, we have several different scenarios about the Powder-based Needle Free Injector YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Powder-based Needle Free Injector will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Powder-based Needle Free Injector market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Powder-based Needle Free Injector market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Powder-based Needle Free Injector market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Production and Pricing Analyses
Readers are provided with deeper production analysis, import and export analysis, and pricing analysis for the global Powder-based Needle Free Injector market. As part of production analysis, the report offers accurate statistics and figures for production capacity, production volume by region, and global production and production by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for price by manufacturer and price by region for the period 2015-2020 and price by each type segment for the period 2015-2026. The import and export analysis for the global Powder-based Needle Free Injector market has been provided based on region.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Powder-based Needle Free Injector market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of volume for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Powder-based Needle Free Injector market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Powder-based Needle Free Injector market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Powder-based Needle Free Injector market.
The following manufacturers are covered in this report:
Antares Pharma
Bioject Medical Technologies
Medical International Technology
Endo International
National Medical Products
Valeritas
European Pharma Group
Crossject SA
Powder-based Needle Free Injector Breakdown Data by Type
Jet
Spring
Laser
Vibration
Powder-based Needle Free Injector Breakdown Data by Application
Cardiovascular Surgeries
General Surgeries
Gynecological Surgeries
Orthopedic Surgeries
Ophthalmic Surgeries
Other Surgeries
1.1 Powder-based Needle Free Injector Product Introduction
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered: Ranking of Global Top Powder-based Needle Free Injector Manufacturers by Revenue in 2019
1.4 Market by Type
1.4.1 Global Powder-based Needle Free Injector Market Size Growth Rate by Type
1.4.2 Jet
1.4.3 Spring
1.4.4 Laser
1.4.5 Vibration
1.5 Market by Application
1.5.1 Global Powder-based Needle Free Injector Market Size Growth Rate by Application
1.5.2 Cardiovascular Surgeries
1.5.3 General Surgeries
1.5.4 Gynecological Surgeries
1.5.5 Orthopedic Surgeries
1.5.6 Ophthalmic Surgeries
1.5.7 Other Surgeries
1.6 Coronavirus Disease 2019 (Covid-19): Powder-based Needle Free Injector Industry Impact
1.6.1 How the Covid-19 is Affecting the Powder-based Needle Free Injector Industry
1.6.1.1 Powder-based Needle Free Injector Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Powder-based Needle Free Injector Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Powder-based Needle Free Injector Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Powder-based Needle Free Injector Market Size Estimates and Forecasts
2.1.1 Global Powder-based Needle Free Injector Revenue Estimates and Forecasts 2015-2026
2.1.2 Global Powder-based Needle Free Injector Production Capacity Estimates and Forecasts 2015-2026
2.1.3 Global Powder-based Needle Free Injector Production Estimates and Forecasts 2015-2026
2.2 Global Powder-based Needle Free Injector Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Global Powder-based Needle Free Injector Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.3.3 Global Powder-based Needle Free Injector Manufacturers Geographical Distribution
2.4 Key Trends for Powder-based Needle Free Injector Markets & Products
2.5 Primary Interviews with Key Powder-based Needle Free Injector Players (Opinion Leaders)
3 Market Size by Manufacturers
3.1 Global Top Powder-based Needle Free Injector Manufacturers by Production Capacity
3.1.1 Global Top Powder-based Needle Free Injector Manufacturers by Production Capacity (2015-2020)
3.1.2 Global Top Powder-based Needle Free Injector Manufacturers by Production (2015-2020)
3.1.3 Global Top Powder-based Needle Free Injector Manufacturers Market Share by Production
3.2 Global Top Powder-based Needle Free Injector Manufacturers by Revenue
3.2.1 Global Top Powder-based Needle Free Injector Manufacturers by Revenue (2015-2020)
3.2.2 Global Top Powder-based Needle Free Injector Manufacturers Market Share by Revenue (2015-2020)
3.2.3 Global Top 10 and Top 5 Companies by Powder-based Needle Free Injector Revenue in 2019
3.3 Global Powder-based Needle Free Injector Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans
4 Powder-based Needle Free Injector Production by Regions
4.1 Global Powder-based Needle Free Injector Historic Market Facts & Figures by Regions
4.1.1 Global Top Powder-based Needle Free Injector Regions by Production (2015-2020)
4.1.2 Global Top Powder-based Needle Free Injector Regions by Revenue (2015-2020)
4.2 North America
4.2.1 North America Powder-based Needle Free Injector Production (2015-2020)
4.2.2 North America Powder-based Needle Free Injector Revenue (2015-2020)
4.2.3 Key Players in North America
4.2.4 North America Powder-based Needle Free Injector Import & Export (2015-2020)
4.3 Europe
4.3.1 Europe Powder-based Needle Free Injector Production (2015-2020)
4.3.2 Europe Powder-based Needle Free Injector Revenue (2015-2020)
4.3.3 Key Players in Europe
4.3.4 Europe Powder-based Needle Free Injector Import & Export (2015-2020)
4.4 China
4.4.1 China Powder-based Needle Free Injector Production (2015-2020)
4.4.2 China Powder-based Needle Free Injector Revenue (2015-2020)
4.4.3 Key Players in China
4.4.4 China Powder-based Needle Free Injector Import & Export (2015-2020)
4.5 Japan
4.5.1 Japan Powder-based Needle Free Injector Production (2015-2020)
4.5.2 Japan Powder-based Needle Free Injector Revenue (2015-2020)
4.5.3 Key Players in Japan
4.5.4 Japan Powder-based Needle Free Injector Import & Export (2015-2020)
5 Powder-based Needle Free Injector Consumption by Region
5.1 Global Top Powder-based Needle Free Injector Regions by Consumption
5.1.1 Global Top Powder-based Needle Free Injector Regions by Consumption (2015-2020)
5.1.2 Global Top Powder-based Needle Free Injector Regions Market Share by Consumption (2015-2020)
5.2 North America
5.2.1 North America Powder-based Needle Free Injector Consumption by Application
5.2.2 North America Powder-based Needle Free Injector Consumption by Countries
5.2.3 U.S.
5.2.4 Canada
5.3 Europe
5.3.1 Europe Powder-based Needle Free Injector Consumption by Application
5.3.2 Europe Powder-based Needle Free Injector Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 U.K.
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Powder-based Needle Free Injector Consumption by Application
5.4.2 Asia Pacific Powder-based Needle Free Injector Consumption by Regions
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Taiwan
5.4.9 Indonesia
5.4.10 Thailand
5.4.11 Malaysia
5.4.12 Philippines
5.4.13 Vietnam
5.5 Central & South America
5.5.1 Central & South America Powder-based Needle Free Injector Consumption by Application
5.5.2 Central & South America Powder-based Needle Free Injector Consumption by Country
5.5.3 Mexico
5.5.3 Brazil
5.5.3 Argentina
5.6 Middle East and Africa
5.6.1 Middle East and Africa Powder-based Needle Free Injector Consumption by Application
5.6.2 Middle East and Africa Powder-based Needle Free Injector Consumption by Countries
5.6.3 Turkey
5.6.4 Saudi Arabia
5.6.5 U.A.E
6 Market Size by Type (2015-2026)
6.1 Global Powder-based Needle Free Injector Market Size by Type (2015-2020)
6.1.1 Global Powder-based Needle Free Injector Production by Type (2015-2020)
6.1.2 Global Powder-based Needle Free Injector Revenue by Type (2015-2020)
6.1.3 Powder-based Needle Free Injector Price by Type (2015-2020)
6.2 Global Powder-based Needle Free Injector Market Forecast by Type (2021-2026)
6.2.1 Global Powder-based Needle Free Injector Production Forecast by Type (2021-2026)
6.2.2 Global Powder-based Needle Free Injector Revenue Forecast by Type (2021-2026)
6.2.3 Global Powder-based Needle Free Injector Price Forecast by Type (2021-2026)
6.3 Global Powder-based Needle Free Injector Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 Market Size by Application (2015-2026)
7.2.1 Global Powder-based Needle Free Injector Consumption Historic Breakdown by Application (2015-2020)
7.2.2 Global Powder-based Needle Free Injector Consumption Forecast by Application (2021-2026)
8 Corporate Profiles
8.1 Antares Pharma
8.1.1 Antares Pharma Corporation Information
8.1.2 Antares Pharma Overview and Its Total Revenue
8.1.3 Antares Pharma Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.1.4 Antares Pharma Product Description
8.1.5 Antares Pharma Recent Development
8.2 Bioject Medical Technologies
8.2.1 Bioject Medical Technologies Corporation Information
8.2.2 Bioject Medical Technologies Overview and Its Total Revenue
8.2.3 Bioject Medical Technologies Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.2.4 Bioject Medical Technologies Product Description
8.2.5 Bioject Medical Technologies Recent Development
8.3 Medical International Technology
8.3.1 Medical International Technology Corporation Information
8.3.2 Medical International Technology Overview and Its Total Revenue
8.3.3 Medical International Technology Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.3.4 Medical International Technology Product Description
8.3.5 Medical International Technology Recent Development
8.4 Endo International
8.4.1 Endo International Corporation Information
8.4.2 Endo International Overview and Its Total Revenue
8.4.3 Endo International Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.4.4 Endo International Product Description
8.4.5 Endo International Recent Development
8.5 National Medical Products
8.5.1 National Medical Products Corporation Information
8.5.2 National Medical Products Overview and Its Total Revenue
8.5.3 National Medical Products Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.5.4 National Medical Products Product Description
8.5.5 National Medical Products Recent Development
8.6 Valeritas
8.6.1 Valeritas Corporation Information
8.6.2 Valeritas Overview and Its Total Revenue
8.6.3 Valeritas Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.6.4 Valeritas Product Description
8.6.5 Valeritas Recent Development
8.7 European Pharma Group
8.7.1 European Pharma Group Corporation Information
8.7.2 European Pharma Group Overview and Its Total Revenue
8.7.3 European Pharma Group Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.7.4 European Pharma Group Product Description
8.7.5 European Pharma Group Recent Development
8.8 Crossject SA
8.8.1 Crossject SA Corporation Information
8.8.2 Crossject SA Overview and Its Total Revenue
8.8.3 Crossject SA Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.8.4 Crossject SA Product Description
8.8.5 Crossject SA Recent Development
9 Production Forecasts by Regions
9.1 Global Top Powder-based Needle Free Injector Regions Forecast by Revenue (2021-2026)
9.2 Global Top Powder-based Needle Free Injector Regions Forecast by Production (2021-2026)
9.3 Key Powder-based Needle Free Injector Production Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
10 Powder-based Needle Free Injector Consumption Forecast by Region
10.1 Global Powder-based Needle Free Injector Consumption Forecast by Region (2021-2026)
10.2 North America Powder-based Needle Free Injector Consumption Forecast by Region (2021-2026)
10.3 Europe Powder-based Needle Free Injector Consumption Forecast by Region (2021-2026)
10.4 Asia Pacific Powder-based Needle Free Injector Consumption Forecast by Region (2021-2026)
10.5 Latin America Powder-based Needle Free Injector Consumption Forecast by Region (2021-2026)
10.6 Middle East and Africa Powder-based Needle Free Injector Consumption Forecast by Region (2021-2026)
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Powder-based Needle Free Injector Sales Channels
11.2.2 Powder-based Needle Free Injector Distributors
11.3 Powder-based Needle Free Injector Customers
12 Market Opportunities & Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Porter's Five Forces Analysis
13 Key Finding in The Global Powder-based Needle Free Injector Study
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Table 1. Powder-based Needle Free Injector Key Market Segments in This Study
Table 2. Ranking of Global Top Powder-based Needle Free Injector Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Powder-based Needle Free Injector Market Size Growth Rate by Type 2020-2026 (K Units) (Million US$)
Table 4. Major Manufacturers of Jet
Table 5. Major Manufacturers of Spring
Table 6. Major Manufacturers of Laser
Table 7. Major Manufacturers of Vibration
Table 8. COVID-19 Impact Global Market: (Four Powder-based Needle Free Injector Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Powder-based Needle Free Injector Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Powder-based Needle Free Injector Players to Combat Covid-19 Impact
Table 13. Global Powder-based Needle Free Injector Market Size Growth Rate by Application 2020-2026 (K Units)
Table 14. Global Powder-based Needle Free Injector Market Size by Region in US$ Million: 2015 VS 2020 VS 2026
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Powder-based Needle Free Injector by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Powder-based Needle Free Injector as of 2019)
Table 17. Powder-based Needle Free Injector Manufacturing Base Distribution and Headquarters
Table 18. Manufacturers Powder-based Needle Free Injector Product Offered
Table 19. Date of Manufacturers Enter into Powder-based Needle Free Injector Market
Table 20. Key Trends for Powder-based Needle Free Injector Markets & Products
Table 21. Main Points Interviewed from Key Powder-based Needle Free Injector Players
Table 22. Global Powder-based Needle Free Injector Production Capacity by Manufacturers (2015-2020) (K Units)
Table 23. Global Powder-based Needle Free Injector Production Share by Manufacturers (2015-2020)
Table 24. Powder-based Needle Free Injector Revenue by Manufacturers (2015-2020) (Million US$)
Table 25. Powder-based Needle Free Injector Revenue Share by Manufacturers (2015-2020)
Table 26. Powder-based Needle Free Injector Price by Manufacturers 2015-2020 (USD/Unit)
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Powder-based Needle Free Injector Production by Regions (2015-2020) (K Units)
Table 29. Global Powder-based Needle Free Injector Production Market Share by Regions (2015-2020)
Table 30. Global Powder-based Needle Free Injector Revenue by Regions (2015-2020) (US$ Million)
Table 31. Global Powder-based Needle Free Injector Revenue Market Share by Regions (2015-2020)
Table 32. Key Powder-based Needle Free Injector Players in North America
Table 33. Import & Export of Powder-based Needle Free Injector in North America (K Units)
Table 34. Key Powder-based Needle Free Injector Players in Europe
Table 35. Import & Export of Powder-based Needle Free Injector in Europe (K Units)
Table 36. Key Powder-based Needle Free Injector Players in China
Table 37. Import & Export of Powder-based Needle Free Injector in China (K Units)
Table 38. Key Powder-based Needle Free Injector Players in Japan
Table 39. Import & Export of Powder-based Needle Free Injector in Japan (K Units)
Table 40. Global Powder-based Needle Free Injector Consumption by Regions (2015-2020) (K Units)
Table 41. Global Powder-based Needle Free Injector Consumption Market Share by Regions (2015-2020)
Table 42. North America Powder-based Needle Free Injector Consumption by Application (2015-2020) (K Units)
Table 43. North America Powder-based Needle Free Injector Consumption by Countries (2015-2020) (K Units)
Table 44. Europe Powder-based Needle Free Injector Consumption by Application (2015-2020) (K Units)
Table 45. Europe Powder-based Needle Free Injector Consumption by Countries (2015-2020) (K Units)
Table 46. Asia Pacific Powder-based Needle Free Injector Consumption by Application (2015-2020) (K Units)
Table 47. Asia Pacific Powder-based Needle Free Injector Consumption Market Share by Application (2015-2020) (K Units)
Table 48. Asia Pacific Powder-based Needle Free Injector Consumption by Regions (2015-2020) (K Units)
Table 49. Latin America Powder-based Needle Free Injector Consumption by Application (2015-2020) (K Units)
Table 50. Latin America Powder-based Needle Free Injector Consumption by Countries (2015-2020) (K Units)
Table 51. Middle East and Africa Powder-based Needle Free Injector Consumption by Application (2015-2020) (K Units)
Table 52. Middle East and Africa Powder-based Needle Free Injector Consumption by Countries (2015-2020) (K Units)
Table 53. Global Powder-based Needle Free Injector Production by Type (2015-2020) (K Units)
Table 54. Global Powder-based Needle Free Injector Production Share by Type (2015-2020)
Table 55. Global Powder-based Needle Free Injector Revenue by Type (2015-2020) (Million US$)
Table 56. Global Powder-based Needle Free Injector Revenue Share by Type (2015-2020)
Table 57. Powder-based Needle Free Injector Price by Type 2015-2020 (USD/Unit)
Table 58. Global Powder-based Needle Free Injector Consumption by Application (2015-2020) (K Units)
Table 59. Global Powder-based Needle Free Injector Consumption by Application (2015-2020) (K Units)
Table 60. Global Powder-based Needle Free Injector Consumption Share by Application (2015-2020)
Table 61. Antares Pharma Corporation Information
Table 62. Antares Pharma Description and Major Businesses
Table 63. Antares Pharma Powder-based Needle Free Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 64. Antares Pharma Product
Table 65. Antares Pharma Recent Development
Table 66. Bioject Medical Technologies Corporation Information
Table 67. Bioject Medical Technologies Description and Major Businesses
Table 68. Bioject Medical Technologies Powder-based Needle Free Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 69. Bioject Medical Technologies Product
Table 70. Bioject Medical Technologies Recent Development
Table 71. Medical International Technology Corporation Information
Table 72. Medical International Technology Description and Major Businesses
Table 73. Medical International Technology Powder-based Needle Free Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 74. Medical International Technology Product
Table 75. Medical International Technology Recent Development
Table 76. Endo International Corporation Information
Table 77. Endo International Description and Major Businesses
Table 78. Endo International Powder-based Needle Free Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 79. Endo International Product
Table 80. Endo International Recent Development
Table 81. National Medical Products Corporation Information
Table 82. National Medical Products Description and Major Businesses
Table 83. National Medical Products Powder-based Needle Free Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 84. National Medical Products Product
Table 85. National Medical Products Recent Development
Table 86. Valeritas Corporation Information
Table 87. Valeritas Description and Major Businesses
Table 88. Valeritas Powder-based Needle Free Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 89. Valeritas Product
Table 90. Valeritas Recent Development
Table 91. European Pharma Group Corporation Information
Table 92. European Pharma Group Description and Major Businesses
Table 93. European Pharma Group Powder-based Needle Free Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 94. European Pharma Group Product
Table 95. European Pharma Group Recent Development
Table 96. Crossject SA Corporation Information
Table 97. Crossject SA Description and Major Businesses
Table 98. Crossject SA Powder-based Needle Free Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 99. Crossject SA Product
Table 100. Crossject SA Recent Development
Table 101. Global Powder-based Needle Free Injector Revenue Forecast by Region (2021-2026) (Million US$)
Table 102. Global Powder-based Needle Free Injector Production Forecast by Regions (2021-2026) (K Units)
Table 103. Global Powder-based Needle Free Injector Production Forecast by Type (2021-2026) (K Units)
Table 104. Global Powder-based Needle Free Injector Revenue Forecast by Type (2021-2026) (Million US$)
Table 105. North America Powder-based Needle Free Injector Consumption Forecast by Regions (2021-2026) (K Units)
Table 106. Europe Powder-based Needle Free Injector Consumption Forecast by Regions (2021-2026) (K Units)
Table 107. Asia Pacific Powder-based Needle Free Injector Consumption Forecast by Regions (2021-2026) (K Units)
Table 108. Latin America Powder-based Needle Free Injector Consumption Forecast by Regions (2021-2026) (K Units)
Table 109. Middle East and Africa Powder-based Needle Free Injector Consumption Forecast by Regions (2021-2026) (K Units)
Table 110. Powder-based Needle Free Injector Distributors List
Table 111. Powder-based Needle Free Injector Customers List
Table 112. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 113. Key Challenges
Table 114. Market Risks
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Fifures
Figure 1. Powder-based Needle Free Injector Product Picture
Figure 2. Global Powder-based Needle Free Injector Production Market Share by Type in 2020 & 2026
Figure 3. Jet Product Picture
Figure 4. Spring Product Picture
Figure 5. Laser Product Picture
Figure 6. Vibration Product Picture
Figure 7. Global Powder-based Needle Free Injector Consumption Market Share by Application in 2020 & 2026
Figure 8. Cardiovascular Surgeries
Figure 9. General Surgeries
Figure 10. Gynecological Surgeries
Figure 11. Orthopedic Surgeries
Figure 12. Ophthalmic Surgeries
Figure 13. Other Surgeries
Figure 14. Powder-based Needle Free Injector Report Years Considered
Figure 15. Global Powder-based Needle Free Injector Revenue 2015-2026 (Million US$)
Figure 16. Global Powder-based Needle Free Injector Production Capacity 2015-2026 (K Units)
Figure 17. Global Powder-based Needle Free Injector Production 2015-2026 (K Units)
Figure 18. Global Powder-based Needle Free Injector Market Share Scenario by Region in Percentage: 2020 Versus 2026
Figure 19. Powder-based Needle Free Injector Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Powder-based Needle Free Injector Production Share by Manufacturers in 2015
Figure 21. The Top 10 and Top 5 Players Market Share by Powder-based Needle Free Injector Revenue in 2019
Figure 22. Global Powder-based Needle Free Injector Production Market Share by Region (2015-2020)
Figure 23. Powder-based Needle Free Injector Production Growth Rate in North America (2015-2020) (K Units)
Figure 24. Powder-based Needle Free Injector Revenue Growth Rate in North America (2015-2020) (US$ Million)
Figure 25. Powder-based Needle Free Injector Production Growth Rate in Europe (2015-2020) (K Units)
Figure 26. Powder-based Needle Free Injector Revenue Growth Rate in Europe (2015-2020) (US$ Million)
Figure 27. Powder-based Needle Free Injector Production Growth Rate in China (2015-2020) (K Units)
Figure 28. Powder-based Needle Free Injector Revenue Growth Rate in China (2015-2020) (US$ Million)
Figure 29. Powder-based Needle Free Injector Production Growth Rate in Japan (2015-2020) (K Units)
Figure 30. Powder-based Needle Free Injector Revenue Growth Rate in Japan (2015-2020) (US$ Million)
Figure 31. Global Powder-based Needle Free Injector Consumption Market Share by Regions 2015-2020
Figure 32. North America Powder-based Needle Free Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 33. North America Powder-based Needle Free Injector Consumption Market Share by Application in 2019
Figure 34. North America Powder-based Needle Free Injector Consumption Market Share by Countries in 2019
Figure 35. U.S. Powder-based Needle Free Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 36. Canada Powder-based Needle Free Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 37. Europe Powder-based Needle Free Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 38. Europe Powder-based Needle Free Injector Consumption Market Share by Application in 2019
Figure 39. Europe Powder-based Needle Free Injector Consumption Market Share by Countries in 2019
Figure 40. Germany Powder-based Needle Free Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 41. France Powder-based Needle Free Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 42. U.K. Powder-based Needle Free Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 43. Italy Powder-based Needle Free Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 44. Russia Powder-based Needle Free Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 45. Asia Pacific Powder-based Needle Free Injector Consumption and Growth Rate (K Units)
Figure 46. Asia Pacific Powder-based Needle Free Injector Consumption Market Share by Application in 2019
Figure 47. Asia Pacific Powder-based Needle Free Injector Consumption Market Share by Regions in 2019
Figure 48. China Powder-based Needle Free Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 49. Japan Powder-based Needle Free Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 50. South Korea Powder-based Needle Free Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 51. India Powder-based Needle Free Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 52. Australia Powder-based Needle Free Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 53. Taiwan Powder-based Needle Free Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 54. Indonesia Powder-based Needle Free Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 55. Thailand Powder-based Needle Free Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 56. Malaysia Powder-based Needle Free Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 57. Philippines Powder-based Needle Free Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 58. Vietnam Powder-based Needle Free Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 59. Latin America Powder-based Needle Free Injector Consumption and Growth Rate (K Units)
Figure 60. Latin America Powder-based Needle Free Injector Consumption Market Share by Application in 2019
Figure 61. Latin America Powder-based Needle Free Injector Consumption Market Share by Countries in 2019
Figure 62. Mexico Powder-based Needle Free Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 63. Brazil Powder-based Needle Free Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 64. Argentina Powder-based Needle Free Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 65. Middle East and Africa Powder-based Needle Free Injector Consumption and Growth Rate (K Units)
Figure 66. Middle East and Africa Powder-based Needle Free Injector Consumption Market Share by Application in 2019
Figure 67. Middle East and Africa Powder-based Needle Free Injector Consumption Market Share by Countries in 2019
Figure 68. Turkey Powder-based Needle Free Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 69. Saudi Arabia Powder-based Needle Free Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 70. U.A.E Powder-based Needle Free Injector Consumption and Growth Rate (2015-2020) (K Units)
Figure 71. Global Powder-based Needle Free Injector Production Market Share by Type (2015-2020)
Figure 72. Global Powder-based Needle Free Injector Production Market Share by Type in 2019
Figure 73. Global Powder-based Needle Free Injector Revenue Market Share by Type (2015-2020)
Figure 74. Global Powder-based Needle Free Injector Revenue Market Share by Type in 2019
Figure 75. Global Powder-based Needle Free Injector Production Market Share Forecast by Type (2021-2026)
Figure 76. Global Powder-based Needle Free Injector Revenue Market Share Forecast by Type (2021-2026)
Figure 77. Global Powder-based Needle Free Injector Market Share by Price Range (2015-2020)
Figure 78. Global Powder-based Needle Free Injector Consumption Market Share by Application (2015-2020)
Figure 79. Global Powder-based Needle Free Injector Value (Consumption) Market Share by Application (2015-2020)
Figure 80. Global Powder-based Needle Free Injector Consumption Market Share Forecast by Application (2021-2026)
Figure 81. Antares Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 82. Bioject Medical Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 83. Medical International Technology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 84. Endo International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 85. National Medical Products Total Revenue (US$ Million): 2019 Compared with 2018
Figure 86. Valeritas Total Revenue (US$ Million): 2019 Compared with 2018
Figure 87. European Pharma Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Crossject SA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Global Powder-based Needle Free Injector Revenue Forecast by Regions (2021-2026) (US$ Million)
Figure 90. Global Powder-based Needle Free Injector Revenue Market Share Forecast by Regions ((2021-2026))
Figure 91. Global Powder-based Needle Free Injector Production Forecast by Regions (2021-2026) (K Units)
Figure 92. North America Powder-based Needle Free Injector Production Forecast (2021-2026) (K Units)
Figure 93. North America Powder-based Needle Free Injector Revenue Forecast (2021-2026) (US$ Million)
Figure 94. Europe Powder-based Needle Free Injector Production Forecast (2021-2026) (K Units)
Figure 95. Europe Powder-based Needle Free Injector Revenue Forecast (2021-2026) (US$ Million)
Figure 96. China Powder-based Needle Free Injector Production Forecast (2021-2026) (K Units)
Figure 97. China Powder-based Needle Free Injector Revenue Forecast (2021-2026) (US$ Million)
Figure 98. Japan Powder-based Needle Free Injector Production Forecast (2021-2026) (K Units)
Figure 99. Japan Powder-based Needle Free Injector Revenue Forecast (2021-2026) (US$ Million)
Figure 100. Global Powder-based Needle Free Injector Consumption Market Share Forecast by Region (2021-2026)
Figure 101. Powder-based Needle Free Injector Value Chain
Figure 102. Channels of Distribution
Figure 103. Distributors Profiles
Figure 104. Porter's Five Forces Analysis
Figure 105. Bottom-up and Top-down Approaches for This Report
Figure 106. Data Triangulation
Figure 107. Key Executives Interviewed
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
